We found that NF-κB and the fibroblast marker protein α-SMA may be important downstream targets of FXR regulation through various bioinformatics methods, suggesting that FXR/NF-κB/α-SMA-related signaling pathways were perhaps new targets for intervention in LN and renal fibrosis. This evidence concerns the gene NFKB1 and renal fibrosis.